KBLBOTCPlastic Material, Synth Resin/Rubber, Cellulos (No Glass)Fiscal year ends December 31
Kraig Biocraft Laboratories, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.08−0.00 (-4.70%)
Close on Oct 19, 2026
- Market cap
- $90.05M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
Kraig Biocraft Laboratories has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements Kraig Biocraft Laboratories filed with the SEC
Biocraft Laboratories Secures $10 Million SEPA to Support Spider Silk Production Growth and Commercialization
Material agreement · Unregistered share sale · Regulation FD disclosure · EX-99.1 to Form 8-K
Biocraft Laboratories Closes Additional Funding Agreement
Material agreement · New financial obligation · Other events · EX-99.1 to Form 8-K